SG Capital Management’s Medtronic MDT Stock Holding History

SG Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-41,248	Closed	-$3.75M	–	53
2018 Q4	$3.75M	Buy	+41,248	New	+$3.85M	1.12%	28

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SG Capital Management's MDT Position: Q1 2019 in Review

SG Capital Management sold out of Medtronic (MDT) in Q1 2019, closing a stake of 41,248 shares — an estimated $3.75M sold.

SG Capital Management first reported a position in MDT in Q4 2018 and held it in 1 quarter. The position peaked at $3.75M in Q4 2018. 1,602 funds tracked by Wall St. Rank hold MDT as of Q1 2019.

SG Capital Management reported no remaining Medtronic position as of Q1 2019 after selling out during the quarter.
SG Capital Management sold 41,248 Medtronic shares in Q1 2019, an estimated $3.75M.
SG Capital Management first reported a position in Medtronic in Q4 2018 and held it in 1 quarter.
SG Capital Management's Medtronic position peaked at $3.75M in Q4 2018.
1,602 funds tracked by Wall St. Rank held Medtronic as of Q1 2019.

Based on SG Capital Management's 13F filing for Q1 2019, filed 16 Apr 2019.